Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Non-invasive Brain Stimulation System Market Outlook (2022 to 2032)

According to Future Market Insight estimation, the non-invasive brain stimulation systems market will be worth US$1,200.5 million by 2022. To reach US$ 2,429.3 million by 2032, the market is anticipated to grow at a CAGR of 6.6% over the forecast period (2022 to 2032).

Numerous neurological conditions, such as Parkinson's disease and tremors, have become more prevalent in recent years. This has resulted in an increase in the demand for non-invasive brain stimulation systems, which is creating the potential for businesses to generate revenue. Given a number of benefits, such as quicker recovery time, non-invasive stimulation is favored by individuals all over the world. In light of this, non-invasive brain stimulation systems market participants see attractive opportunities in many developed and developing countries.

Report Attribute Details
Non-invasive Brain Stimulation System Market Historical Growth Rate (2017 to 2021) 17.6%
Non-invasive Brain Stimulation System Market Value (2022) US$ 1,200.5 million
Non-invasive Brain Stimulation System Market Anticipated Forecast Value (2032) US$ 2,429.3 million
Non-invasive Brain Stimulation System Market Projected Growth Rate (2022 to 2032) 6.6%

The most important aspects projected to drive the non-invasive brain stimulation system market during the forecast period are the growing occurrence of neurological disorders, the upsurge of non-invasive and minimally invasive measures, the practice of casualty techniques, rushing geriatric population leading to growing brain disorders associated with age, mounting uses of the transcranial magnetic stimulation method in diagnosis, treatment of neurological disorders, satisfactory reimbursements, and innovative and scientifically advanced products presented by companies such as neuro-navigating stimulators in the global market.

Additionally, young people, these days use mobile devices extensively. As a result, people's nervous systems are affected by persistent exposure to radiation from technology, which can lead to a variety of neurological illnesses.

The Food and Drug Administration (FDA) has authorized a non-invasive brain stimulation device for the treatment of depressive disorders. Transcranial stimulation (TCS) has not been well studied, although transcranial magnetic stimulation (TMS) has been licensed for the treatment of depressive disorders.

According to the World Health Organization, the elderly population is predicted to expand more quickly in affluent countries, notably the United States of America, Japan, and numerous European nations. Treatments for depression, tinnitus, stroke, and other neurological illnesses using TMS and TCS have shown promising results. This procedure does not call for an overnight stay and is administered at specialist clinics, outpatient clinics, hospitals, and other settings. As soon as the therapy is through, patients are free to return home.

Due to increased awareness of the adverse effects of drug treatment, healthcare professionals and patient groups worldwide are increasingly choosing non-invasive brain stimulation systems over it. This element is opening up enormous commercial opportunities in the market for non-invasive brain stimulation systems. Owing to a focus on organic growth of the non-invasive brain stimulation system market by many businesses, there are likely to be breakthroughs in non-invasive brain stimulation systems in the upcoming years. These developments will help physicians with a variety of outpatient devices and give patients new therapies in cases where conventional therapies fail.

Players in the global non-invasive brain stimulation system market are investing more in Research and Development to enhance their products' overall performance, particularly battery life. Additionally, producers of non-invasive brain stimulation systems are working to improve a number of patient-related aspects, such as reliability in IPG recharging and consistency in nocturnal device endpoint.

Many manufacturers of non-invasive brain stimulation systems are focusing on adding device-specific features such as lead configuration, parameter delivery, and implantation site. In a similar vein, they carefully choose electrode materials to minimize impedance mismatch. During the forecast period, these elements are anticipated to encourage the expansion of the non-invasive brain stimulation system market worldwide.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Growing Prevalence of Neurological Disorders and Diseases is Driving Demand for Non-Invasive Brain Stimulation Systems

The market for non-invasive brain stimulation systems is predicted to see growth due to an increase in the number of persons suffering from neurological illnesses in key regions of the world. Neurological problems are becoming more common as the geriatric population worldwide goes up. This is driving up demand for non-invasive brain stimulation systems, which is, in turn, driving up market expansion.

Governments of many developed and developing countries provide enticing reimbursement plans for healthcare institutions. The non-invasive brain stimulation system market is growing in terms of sales based on this ground as well.

The function of the brain is investigated using functional MRI (magnetic resonance imaging) and EEG (electroencephalogram) methods. The process of stimulating the brain is also used to promote mental activity. The two techniques for brain stimulation are repeated transcranial magnetic stimulation (TMS) and transcranial current stimulation (TCS). These two procedures, which are collectively referred to as non-invasive brain stimulation, are used to both enhance brain function and disrupt brain activity. Over the forecast period, the increasing relevance of these techniques is anticipated to encourage the growth of the worldwide non-invasive brain stimulation system market.

The industry's leading companies are concentrating on getting new non-invasive brain stimulation systems approved and put on the market in order to increase the variety of products they provide. In addition, major industry competitors are concentrating on releasing improved versions of their non-invasive brain stimulation systems in the market. The industry is anticipated to increase as new technologies are increasingly used by hospitals.

Alternative Treatment Methods' Accessibility Probably Limit the Non-invasive Brain Stimulation Systems Market Growth

The hazards associated with deep brain stimulation treatments, such as lead misplacement and brain haemorrhage, are one of the main reasons impeding the growth of the global non-invasive brain stimulation system market. The risk of infections brought on by IPG is expected to limit the adoption of a Non-invasive Brain Stimulation System for Parkinson's disease.

On the other hand, another major restraint concerning the non-invasive brain stimulation systems market during the forecast period is likely to be electroconvulsive therapy. It has clinically demonstrated high efficacy in treating psychotic depression, and the number of patients utilizing the therapy is extremely high.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Presence of Cutting-edge Healthcare Infrastructure Fueling North American Market Enlargement

North America is predicted to dominate the global non-invasive brain stimulation systems market during the forecast period holding nearly 34.6% market share in 2022. a sizable population with depression and other neurological and psychological disorders, the presence of cutting-edge healthcare infrastructure and technologies, the availability of integrated healthcare IT products to maintain electronic health records, investments by governments in the creation of revolutionary medical devices, the availability of skilled and trained professionals, favorable reimbursement policies, and an increase in the adoption of advanced products are all contributing to the market growth in the region.

Statistics from the Centers for Disease Control and Prevention (CDC) show that between 3.5 million and 4 million persons in the United States of America alone have depression that is resistant to therapy. In order to enhance equipment and technology and broaden the range of uses for non-invasive brain stimulation systems, there has been an increase in partnerships and cooperation between businesses and research universities on the international market. The market participants operating in the region have several prospects as a result of this and the rising number of approvals.

Rising Prevalence of Psychological Disorders is Pushing European Market Expansion

The second-largest market after the United States of America, Europe has had tremendous economic growth and increased healthcare access which resulted in the region holding almost 31.7% market share. This has created a market opportunity for producers of innovative and non-invasive devices. During the forecast period, factors such as rising psychological disorder occurrence, rising health care spending, rising government initiatives, rising Research and Development activities, rising medical tourism, and rising demand for new treatments for these disorders are anticipated to support the growth of the non-invasive brain stimulation system market in Europe.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Start-ups are Stressing on Research and Development for Enhanced Inventions

The therapeutic potential of brain stimulation in the treatment of brain-related illnesses is currently being researched by new entrants.

For instance, LivaNova and MicroPort Scientific got FDA clearance for RegaTM pacemakers in September 2019. On the other hand, OrbiMed Advisors and KCK Groups launched an investment round of USD 74 million that NeuroPace, Inc. concluded last October. With the help of this finance, the business will be able to quickly develop and market its FDA-approved DBS product, the NeuroPace RNS system.

Large Market Players are Concentrating to Produce Comprehensible Products in the Market

Numerous companies in the non-invasive brain stimulation system market are introducing novel, transportable, user-friendly, affordable, and highly effective products. Furthermore, a lot of businesses are concentrating on commercializing their offerings.

Example:

  • In November 2021, for Horizon 3.0, Magstim, a company that offers neuroscience-based mental health treatment and research, gained 510K approval. Since Horizon 3.0 was designed primarily for the clinical context, it offers enhanced workflows with guided TMS and analytics. Magstim Connect is a fresh and powerful patient data management system for TMS, delivering linked treatment at networking sites.
  • In January 2021, Gaelan Medical Trade LLC, a healthcare provider with several distribution channels in the United Arab Emirates, and BrainsWay Ltd., a global leader in non-invasive advanced therapy for brain illnesses, announced an exclusive distribution deal. The agreement establishes a multiyear framework for the marketing and sale of BrainsWay's patented, ground-breaking Deep Transcranial Magnetic Stimulation (Deep TMS) system throughout the United Arab Emirates. Deep TMS is currently marketed in various markets for treating brain disorders like major depressive disorder (MDD) and obsessive-compulsive disorder (OCD), among others.
  • In August 2020, the FDA approved MagVenture TMS Therapy as adjunctive therapy for obsessive-compulsive disorder (OCD). The Danish medical device firm MagVenture has received a second indication in the USA with this product.

Key Players

  • NeoSync, Inc.
  • Highland Instruments
  • MagVenture
  • BrainsWay
  • Magstim

Report Scope

Report Attribute Details
Growth Rate CAGR of 6.6% from 2022 to 2032
Base Year for Estimation 2021
Historical Data 2017 to 2021
Forecast Period 2022 to 2032
Quantitative Units Revenue in USD Billion, Volume in Kilotons, and CAGR from 2022 to 2032
Report Coverage Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segments Covered
  • Product Type
  • Application
  • End-user
  • Region
Regions Covered
  • North America
  • Latin America
  • The Asia Pacific
  • Middle East and Africa
  • Europe
Key Countries Profiled
  • USA
  • Canada
  • Brazil
  • Argentina
  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • Nordics
  • BENELUX
  • Australia & New Zealand
  • China
  • India
  • ASEAN
  • GCC Countries
  • South Africa
Key Companies Profiled
  • NeoSync, Inc.
  • Highland Instruments
  • MagVenture
  • BrainsWay
  • Magstim
Customization Available Upon Request

Key Segments Profiled in the Non-invasive Brain Stimulation System Market

By Product Type:

  • Transcranial Magnetic Stimulation (TMS) System
  • Transcranial Current Stimulation (TCS) System

By Application:

  • Chronic Pain
  • Tremor
  • Depression
  • Epilepsy
  • Parkinson Disease
  • Others

By End-User:

  • Hospital
  • Ambulatory Surgical centers
  • Clinics
  • Specialty Care Unit
  • Others

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia-Pacific
  • Japan
  • Middle East and Africa

Frequently Asked Questions

What is the Growth Outlook for the Non-invasive Brain Stimulation System Market?

The global non-invasive brain stimulation systems market is expected to progress at a CAGR of 6.6% (2022 to 2032).

Which Region is Anticipated to Embrace the Maximum Share in the Global Non-invasive Brain Stimulation System Market?

North America is expected to hold the highest share (34.6%) in the global non-invasive brain stimulation systems market.

What is the Future of the Non-invasive Brain Stimulation System Market?

The global non-invasive brain stimulation systems market is predicted to account for US$ 2,429.3 million by 2032.

Table of Content

1. Executive Summary | Non-invasive Brain Stimulation System Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032

    4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Product Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2017 to 2021

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2022 to 2032

        5.3.1. Transcranial Magnetic Stimulation (TMS) System

        5.3.2. Transcranial Current Stimulation (tCS) System

    5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2021

    5.5. Absolute $ Opportunity Analysis By Product Type, 2022 to 2032

6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Application

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2017 to 2021

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2022 to 2032

        6.3.1. Cronic Pain

        6.3.2. Tremor

        6.3.3. Depression

        6.3.4. Epilepsy

        6.3.5. Parkinson's Disease

        6.3.6. Others

    6.4. Y-o-Y Growth Trend Analysis By Application, 2017 to 2021

    6.5. Absolute $ Opportunity Analysis By Application, 2022 to 2032

7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By End User, 2017 to 2021

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2022 to 2032

        7.3.1. Hospital

        7.3.2. Ambulatory Surgical Centers

        7.3.3. Clinics

        7.3.4. Specialty Care Value (US$ Million)

        7.3.5. Others

    7.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2021

    7.5. Absolute $ Opportunity Analysis By End User, 2022 to 2032

8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021

    8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Western Europe

        8.3.4. Asia Pacific

        8.3.5. Japan

        8.3.6. Middle East and Africa

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        9.2.1. By Country

            9.2.1.1. USA

            9.2.1.2. Canada

        9.2.2. By Product Type

        9.2.3. By Application

        9.2.4. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product Type

        9.3.3. By Application

        9.3.4. By End User

    9.4. Key Takeaways

10. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

        10.2.2. By Product Type

        10.2.3. By Application

        10.2.4. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product Type

        10.3.3. By Application

        10.3.4. By End User

    10.4. Key Takeaways

11. Western Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. Italy

            11.2.1.3. France

            11.2.1.4. United Kingdom

            11.2.1.5. Spain

        11.2.2. By Product Type

        11.2.3. By Application

        11.2.4. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product Type

        11.3.3. By Application

        11.3.4. By End User

    11.4. Key Takeaways

12. Asia Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        12.2.1. By Country

            12.2.1.1. China

            12.2.1.2. India

            12.2.1.3. ASEAN

            12.2.1.4. Australia

            12.2.1.5. New Zealand

        12.2.2. By Product Type

        12.2.3. By Application

        12.2.4. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product Type

        12.3.3. By Application

        12.3.4. By End User

    12.4. Key Takeaways

13. Japan Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        13.2.1. By Country

        13.2.2. By Product Type

        13.2.3. By Application

        13.2.4. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product Type

        13.3.3. By Application

        13.3.4. By End User

    13.4. Key Takeaways

14. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. S. Africa

            14.2.1.3. N. Africa

        14.2.2. By Product Type

        14.2.3. By Application

        14.2.4. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product Type

        14.3.3. By Application

        14.3.4. By End User

    14.4. Key Takeaways

15. Key Countries Market Analysis

    15.1. United Kingdom

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2021

            15.1.2.1. By Product Type

            15.1.2.2. By Application

            15.1.2.3. By End User

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2021

            15.2.2.1. By Product Type

            15.2.2.2. By Application

            15.2.2.3. By End User

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2021

            15.3.2.1. By Product Type

            15.3.2.2. By Application

            15.3.2.3. By End User

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2021

            15.4.2.1. By Product Type

            15.4.2.2. By Application

            15.4.2.3. By End User

    15.5. Rest of Latin America

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2021

            15.5.2.1. By Product Type

            15.5.2.2. By Application

            15.5.2.3. By End User

    15.6. Germany

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2021

            15.6.2.1. By Product Type

            15.6.2.2. By Application

            15.6.2.3. By End User

    15.7. United Kingdom

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2021

            15.7.2.1. By Product Type

            15.7.2.2. By Application

            15.7.2.3. By End User

    15.8. France

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2021

            15.8.2.1. By Product Type

            15.8.2.2. By Application

            15.8.2.3. By End User

    15.9. Spain

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2021

            15.9.2.1. By Product Type

            15.9.2.2. By Application

            15.9.2.3. By End User

    15.10. Italy

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2021

            15.10.2.1. By Product Type

            15.10.2.2. By Application

            15.10.2.3. By End User

    15.11. Rest of Europe

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2021

            15.11.2.1. By Product Type

            15.11.2.2. By Application

            15.11.2.3. By End User

    15.12. China

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2021

            15.12.2.1. By Product Type

            15.12.2.2. By Application

            15.12.2.3. By End User

    15.13. Japan

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2021

            15.13.2.1. By Product Type

            15.13.2.2. By Application

            15.13.2.3. By End User

    15.14. South Korea

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2021

            15.14.2.1. By Product Type

            15.14.2.2. By Application

            15.14.2.3. By End User

    15.15. Malaysia

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2021

            15.15.2.1. By Product Type

            15.15.2.2. By Application

            15.15.2.3. By End User

    15.16. Singapore

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2021

            15.16.2.1. By Product Type

            15.16.2.2. By Application

            15.16.2.3. By End User

    15.17. Australia

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2021

            15.17.2.1. By Product Type

            15.17.2.2. By Application

            15.17.2.3. By End User

    15.18. Rest of Asia Pacific

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2021

            15.18.2.1. By Product Type

            15.18.2.2. By Application

            15.18.2.3. By End User

    15.19. GCC Countries

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2021

            15.19.2.1. By Product Type

            15.19.2.2. By Application

            15.19.2.3. By End User

    15.20. South Africa

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2021

            15.20.2.1. By Product Type

            15.20.2.2. By Application

            15.20.2.3. By End User

    15.21. Israel

        15.21.1. Pricing Analysis

        15.21.2. Market Share Analysis, 2021

            15.21.2.1. By Product Type

            15.21.2.2. By Application

            15.21.2.3. By End User

    15.22. Rest of the Middle East and Africa(MEA)

        15.22.1. Pricing Analysis

        15.22.2. Market Share Analysis, 2021

            15.22.2.1. By Product Type

            15.22.2.2. By Application

            15.22.2.3. By End User

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Product Type

        16.3.3. By Application

        16.3.4. By End User

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. NeoSync, Inc.

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

        17.1.2. Highland Instruments

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

        17.1.3. Mayfield Brain and Spine

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

        17.1.4. Boston Scientific Corporation

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

        17.1.5. Abbott Laboratories

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

        17.1.6. Medtronic plc

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Recommendations

Healthcare

Non-invasive Pulse Wave Tonometer Market

Published : October 2022

Explore Healthcare Insights

View Reports

Non-invasive Brain Stimulation System Market